Counselors in South Chesterfield, VA Accepting Medicare
8 Counselors found. Showing 1 - 8
 Dejon Harris Counselor Medicare: Not Enrolled in Medicare Practice Location: 20012 Loyal Ave, South Chesterfield, VA 23803 Phone: 804-210-0990 |
 Leanora Jane Harkless, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1830 Ruffin Mill Cir Ste B, South Chesterfield, VA 23834 Phone: 804-479-3634 |
Mrs. Danielle N Crane, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 14512 Walthall Dr, South Chesterfield, VA 23834 Phone: 804-571-6131 |
Miss Britni Higginbotham Counselor Medicare: Not Enrolled in Medicare Practice Location: 3604 E River Rd, South Chesterfield, VA 23803 Phone: 804-898-3800 Fax: 804-302-5607 |
Latoya Green Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 19709 Thelma Ave, South Chesterfield, VA 23803 Phone: 804-721-3255 |
Lakeisha Branch Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5700 Fox Hunt Trl, South Chesterfield, VA 23803 Phone: 804-919-1931 |
Dr. Anthony David Mangiafico, PHD, CNS Counselor - Mental Health Medicare: Accepting Medicare Assignments Practice Location: 2552 Aldridge Ave, South Chesterfield, VA 23834 Phone: 804-735-9595 |
Adenike Oluwakemi Okegbenro Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3817 Greenwood Dr, South Chesterfield, VA 23803 Phone: 804-490-3502 Fax: 804-898-3405 |
News Archive
Globe and Mail profiles former President Jimmy Carter, Carter Center's efforts to eradiacate guinea worm
The Globe and Mail profiles former President Jimmy Carter and the Carter Center's decades-long efforts to eradicate guinea worm disease, also known as dracunculiasis. According to the newspaper, "In 2011, there were 1,060 cases of guinea worm disease identified in the world, in four countries," and "staff and volunteers from the Carter Center have visited every one of the 26,500 villages where guinea worm was identified" to provide education on prevention, as well as treatment.
Micromet first quarter total revenues decrease to $5.5 million
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the first quarter ended March 31, 2011.
Chemical first found on Easter Island could treat tuberous sclerosis
A new study has shown promising results in fighting a severe genetic disorder which can create tumours throughout the body.
Discovery holds potential to pave way for new synergistic drug combinations
New data from a study led by researchers from the University of Minnesota Medical School could change how future antimicrobial drug combinations are discovered and developed.
› Verified 7 days ago